TRCT
BIOTU

Tower Research Capital (TRC)’s Biotech Acquisition Company Unit BIOTU Stock Holding History

Tower Research Capital (TRC)’s Portfolio BIOTU Stock Details BIOTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-103
Closed -$1K – 6712
2022
Q4 		$1K Hold
103
– – ﹤0.01% 5798
2022
Q3 		$1K Hold
103
– – ﹤0.01% 5952
2022
Q2 		$1K Buy
+103
New +$1.02K ﹤0.01% 5966

Tower Research Capital (TRC)'s BIOTU Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Biotech Acquisition Company Unit (BIOTU) in Q1 2023, closing a stake of 103 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in BIOTU in Q2 2022 and held it in 3 quarters. The position peaked at $1K in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOTU as of Q1 2023.

  • Tower Research Capital (TRC) reported no remaining Biotech Acquisition Company Unit position as of Q1 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 103 Biotech Acquisition Company Unit shares in Q1 2023, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in Biotech Acquisition Company Unit in Q2 2022 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s Biotech Acquisition Company Unit position peaked at $1K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Biotech Acquisition Company Unit as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.